|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：D193604 |
| 產(chǎn)品名稱：Dasatinib-13C415N2 |
| 產(chǎn)品CAS：1107614-42-5 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
D193604 |
| 名稱: |
Dasatinib-13C415N2 |
| 別名: |
N-[2-Chloro-6-methylphenyl]-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide-13C415N2; BMS-354825-13C415N2; |
| CAS號: |
1107614-42-5 |
| 分子式: |
C??¹³C?H??ClN?¹?N?O?S |
| 分子量: |
493.96 |
| 種類: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Isotope labelled Dasatinib (D193600), A new, oral, small-molecule Tyrosine Kinase Inhibitor (TKI) for the treatment of CML. Antineoplastic. |
| 參考文獻 |
|
|
|
|
?您的位置：
